Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This study aims to test the hypothesis that the artificial prolongation of the platinum-free
interval with a non-platinum treatment will improve the effectiveness of overall therapy in
patients with ovarian cancer progression occurring 6-12 months after first-line treatment
with a platinum-derivative.